WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016064231) METHOD FOR PREDICTING SENSITIVITY TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2016/064231 International Application No.: PCT/KR2015/011238
Publication Date: 28.04.2016 International Filing Date: 22.10.2015
IPC:
C12Q 1/68 (2006.01) ,G01N 33/15 (2006.01)
Applicants: CBSBIOSCIENCE INC.[KR/KR]; 26-69, Gajeongbuk-ro Yuseong-gu Daejeon 34113, KR
GIL MEDICAL CENTER[KR/KR]; 21, Namdong-daero 774beon-gil Namdong-gu Incheon 21565, KR
Inventors: PARK, Jin Young; KR
MOON, Young Ho; KR
KWON, Jung-Hee; KR
KIM, Yun Soo; KR
KIM, Ju Hyun; KR
CHOI, Duck Joo; KR
Agent: AHN, So-Young; KR
Priority Data:
10-2014-014476224.10.2014KR
Title (EN) METHOD FOR PREDICTING SENSITIVITY TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITOR
(FR) PROCÉDÉ DE PRÉDICTION DE LA SENSIBILITÉ À UN INHIBITEUR DU RÉCEPTEUR DU FACTEUR DE CROISSANCE ENDOTHÉLIAL VASCULAIRE
(KO) 혈관 내피 세포 성장인자 수용체 억제제에 대한 감수성 예측 방법
Abstract: front page image
(EN) The present invention relates to a method for predicting the sensitivity to treatment with vascular endothelial growth factor receptor (VEGFR) inhibitors, by using a biomarker. An effective means and anticancer therapy for cancer treatment of liver cancer are selected by predicting the effect of treatment with VEGFR inhibitors on liver cancer patients through the present invention, thereby increasing the treatment effect and minimizing the side effects of liver cancer treatment.
(FR) La présente invention concerne un procédé de prédiction de la sensibilité à un traitement par des inhibiteurs du récepteur du facteur de croissance endothélial vasculaire (VEGFR), en utilisant un marqueur biologique. Un moyen et une thérapie anticancer efficaces de traitement du cancer du foie sont sélectionnés par prévision de l'effet du traitement avec des inhibiteurs du VEGFR sur des patients atteints de cancer du foie, augmentant ainsi l'effet du traitement et réduisant les effets secondaires du traitement du cancer du foie.
(KO) 본 발명은 바이오마커를 이용한 혈관 내피 세포 성장인자 수용체(VEGFR) 억제제로 치료에 대한 감수성을 예측하는 방법에 관한 것이다. 본 발명을 통해 간암 환자의 혈관 내피 세포 성장인자 수용체(VEGFR) 억제제로 치료에 대한 효과를 예측함으로써 간암에 대한 항암 치료를 위한 효과적인 수단 및 항암 요법을 선정하여 치료 효과를 높이고 간암 치료의 부작용을 최소화한다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)